Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Becton, Dickinson and Comp
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:

- medical equipment (52.4%): surgical instruments (71.6% of net sales), pharmaceutical systems (16.2%), and diabetes care products (12.2%);

- diagnostic materials (24.9%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;

- clinical research and development tools (22.7%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.

Net sales are distributed geographically as follows: the United States (56.3%), Europe (19.4%), Asia/Pacific (15.8%) and other (8.5%).

Number of employees : 70 093 people.
Sales per Businesses
20182019Delta
USD (in Million)%USD (in Million)%
Medical8,61653.9%9,06452.4% +5.2%
Life Sciences4,33027.1%4,30024.9% -0.69%
Interventional3,03719%3,92622.7% +29.27%
Sales per Regions
20182019Delta
USD (in Million)%USD (in Million)%
United States8,76854.9%9,73056.3% +10.97%
Europe3,29820.6%3,35919.4% +1.85%
Greater Asia2,46015.4%2,72615.8% +10.81%
Other1,4579.1%1,4768.5% +1.3%
Managers
NameAgeSinceTitle
Thomas Polen452020President & Chief Executive Officer
Vincent Forlenza652020Executive Chairman
Christopher R. Reidy622013Chief Financial Officer, CAO & EVP-Administration
John A. DeFord, Dr.572018Chief Technology Officer & Executive VP
William R. Sigmund, Dr.--Chief Medical Officer & EVP
Jerry Flasz--Chief Information Officer & EVP-Global Services
Bertram L. Scott682002Independent Director
Claire M. Fraser-Liggett, Dr.642006Independent Director
Marshall O. Larsen712012Independent Director
Christopher Ian Montague Jones642010Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 346,687,148 270,719,904 78.1% 75,514,000 21.8% 78.1%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. (Investment Management) 31,917,919 11.8%
The Vanguard Group, Inc. 22,897,636 8.47%
Fidelity Management & Research Co. 11,947,066 4.42%
SSgA Funds Management, Inc. 11,264,298 4.16%
BlackRock Fund Advisors 6,569,786 2.43%
Morgan Stanley Investment Management Ltd. 4,032,882 1.49%
Fundsmith LLP 3,817,935 1.41%
Franklin Advisers, Inc. 3,595,282 1.33%
Geode Capital Management LLC 3,567,578 1.32%
Capital Research & Management Co. 3,311,000 1.22%
Markets and indexes
- NYSE
- Main Market
- SP 500 / Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  BDX:US
- Reuters Code :  BDX
- Datastream Code :  
Company contact information
Becton, Dickinson and Company
1 Becton Drive
NJ 07417 Franklin Lakes, New Jersey
États-Unis (les)

Phone : +1 (201) 847 6800
Fax : +1
Internet : http://www.bd.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Becton, Dickinson and Company
Connections : Becton, Dickinson and Comp